Sequoia monetising bet on drug developer via deal with big pharma firm
Advertisement

Sequoia monetising bet on drug developer via deal with big pharma firm

By Joseph Rai

  • 20 Oct 2020
Premium
Sequoia monetising bet on drug developer via deal with big pharma firm
Credit: 123RF.com

Venture capital firm Sequoia Capital is monetising a part of its investment in a drug development ...

This is a Premium article, Subscribe to read the full story!

Limited Time Offer - Subscribe now & get free access to The Unicorn report.

The year 2021 was a record year for Unicorn activity in India, with 47 new Unicorns being added to the list, from a previous 11 in 2020. Get access to exclusive analysis on growth landscape, sectoral view, future Unicorns & more..

Advertisement
Advertisement